http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Technology, Market and Company Journeys: How Can We Help Them Succeed?
Malcolm, Parry World Technopolis Association 2012 World Technopolis Review Vol.1 No.1
The science and technology park movement has been developing for over 60 years. The first developments simply relied on the co-location of tenant companies and the park's host to encourage technology transfer. This is in contrast with their modern counter parts which offer a range of active links between tenant companies and host organisations as well as a raft of business development services to support technology commercialisation. Many of these sites have also become important centres in regional innovation plans. In these cases they are supported by a range of local, regional and national policies that are aimed at establishing a business, technology and social environment which support innovation. The paper examines both the business development programmes developed by science and technology parks to support technology commercialisation and the macro conditions that are now being developed to support innovation.
Patient reported outcomes in elective laparoscopic cholecystectomy
Malcolm H.W. Mak,Woon Ling Chew,Sameer P. Junnarkar,Winston W.L. Woon,Jee-Keem Low,Terence C.W. Huey,Vishalkumar G. Shelat 한국간담췌외과학회 2019 Annals of hepato-biliary-pancreatic surgery Vol.23 No.1
Backgrounds/Aims: Traditional outcome measures (e.g., length of hospital stay, morbidity, and mortality) are used to determine the quality of care, but these may not be most important to patients. It is unclear which outcomes matter to patients undergoing elective laparoscopic cholecystectomy (ELC). We aim to identify patient-reported outcome measures (PROM) which patients undergoing ELC valued most. Methods: A 45-item questionnaire with Four-point Likert-type questions developed from prior literature review, prospectively administered to patients treated with ELC at a tertiary institution in Singapore. Results: Seventy-five patients participated. Most essential factors were technical skill and experience level of a surgeon, long-term quality of life (QoL), patient involvement in decision-making, communication skill of a surgeon, cleanliness of the ward environment, and standards of nursing care. Least important factors were hospitalization leave duration, length of hospital stay, a family’s opinion of the hospital, and scar cosmesis. Employed patients were more likely to find hospitalization leave duration (p<0.001) and procedure duration (p=0.042) important. Younger patients (p=0.048) and female gender (p=0.003) were more likely to perceive scar cosmesis as important. Conclusions: Patients undergoing ELC value long-term QoL, surgeon technical skill and experience level, patient involvement in decision-making, surgeon communication skill, cleanliness of the ward environment, and nursing care standards. Day-case surgery, medical leave, family opinion of hospital, and scar cosmesis were least important. Understanding what patients value will help guide patient-centric healthcare delivery.
MALCOLM REID W. 대한양계협회 1983 월간 양계 Vol.15 No.2
항콕시듐제를 사료중에 첨가할 때 일어날 수 있는 실수는 두 가지 면에서 양계업자 들에게 큰 손실을 준다. 첫째로 항콕시듐제를 적량보다 적게 투여하거나, 배합시설의 불비로 인하여 적량이 사료 중에 함유되어 있지 않은 경우엔, 콕시듐이 심하게 감염상황인 때 5일에서 7일만에 콕시듐이 발병된다. 그 결과 콕시듐을 예방하고자 투입되는 경비와 노력이 낭비된다. 두째로 적량보다 초과하여 급여하거나 첨가될 때는 사료섭취량의 감소, 증체 및 사료 효율의 불량, 폐사수의 증가를 초래한다. 적량미달 투여와 과량 투여의 영향에 대한 실례를 상세히 기술하여 보고된 것은 그리 많지 않다. 심하게 피해가 발생하였다 하더라도 대개는 인테그레이션 회사나 사료회사 선에서 비밀에 부쳐지며, 증상은 경미하나 경제적으로 심각한 손실을 초래하는 경우에도 사양가들이 그 피해를 알아내는 쉬운 방법이 없기 때문에 그대로 지나친다. 사료중에 첨가되는 항콕시듐제의 첨가수준을 자주 분석$\cdot$점검하는 등의 품질관리 프로그램의 수립 및 이의 수행은 매우 필요한 것임을 강조하는 몇가지 실례를 소개한다.